About 3 billion people are now at risk of Japanese encephalitis (JE) having its focus in South East Asian and Oceanian countries. There is no treatment of this disease and vaccination is still not adopted as a national program by most countries endemic to the disease. Thus this study was aimed to see possible preventive and curative effect of “Belladonna-200” against JE.
The experiment showed that Belladona 200 reduced the severity of Japanese encephalitis by diminishing the viral loads in brain. The study further suggests that pre-treatment of Belladonna 200C may reduce the viral entry, its propagation in different organs particularly in the brain and thus may reduce the pathological sequel of the disease.
This paper explores the use of homeopathy medicines in different stages of Japanese Encephalitis. It was found that Belladonna is useful in first stage of encephalitis without effusion. Helleborus is effective in the second stage of the disease with effusion, stupor, dragging of legs and developing paralysis. Finally Phosphorus is indicated when complete paralysis appears due to inflammation and degeneration of brain cells.
This paper presents a protocol with the objective of investigating, in a randomized, double-blind and placebo-controlled clinical trial, the effectiveness and safety of possible individualized homeopathic drugs of epidemic genius of COVID-19, in adjuvant and complementary treatment of patients affected by the disease. If effectiveness and safety of medicine chosen is confirmed using this protocol, the medicine may be used in a generalized and collective manner in the treatment and prevention of the current epidemic.
This pamphlet was published at Gotha in 1801. This was one of the first works of Dr. Hahnemann wherein he discussed the role of Homeopathic Medicines in Curing and preventing Epidemics. In this paper he discussed the symptoms of then prevalent epidemic of Scarlet Fever and how to use Belladona as preventive for it.